Supplements

Shared decision-making platforms can optimize oxybate therapy selection and outcomes in narcolepsy patients

The review suggests that involving patients in decision-making through shared decision-making (SDM) platforms can be effective for optimizing oxybate therapy in narcolepsy. It highlights the availability of three oxybate formulations (OXB, LXB, SO-ER) and the need for tailored treatment. No quantitative outcomes or effect sizes are reported.

Last updated: Aug 26, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Optimizing patient outcomes and empowering the patient-clinician partnership.

observational

Thorpy M · Sleep advances : a journal of the Sleep Research Society (2026)

Participants: N/A
Duration: N/A
Intervention: Shared decision-making (SDM) platforms for oxybate therapy selection
Outcome: Optimization of oxybate therapy and patient outcomes
Effect Size: N/A
Population: Patients with narcolepsy

Result:

PubMed: 42488173DOI: 10.1093/sleepadvances/zpag034

Mechanism Graph

Clinician reviews available oxybate formulations (OXB, LXB, SO-ER)
↓
Patient preferences and values are incorporated via SDM
↓
Treatment regimen is tailored to individual needs
↓
Result: Optimized therapy and improved patient-clinician partnership

Limitations

  • ⚠The paper is a review article, not an empirical study, so no direct evidence of SDM efficacy is provided
  • ⚠No specific patient outcomes (e.g., sleep latency, adverse events) are quantified

Frequently Asked Questions

What are the three oxybate formulations available for narcolepsy?▼

The three formulations are immediate-release sodium oxybate (OXB), a low-sodium version containing calcium, magnesium, potassium, and sodium oxybates (LXB), and a once-nightly sodium oxybate formulation (SO-ER).

How does shared decision-making help in narcolepsy treatment?▼

Shared decision-making involves patients in the selection and optimization of oxybate therapy, which can lead to more personalized treatment and better patient-clinician partnerships, potentially improving outcomes.

Is there evidence that SDM improves clinical outcomes in narcolepsy?▼

This review article proposes SDM as an effective approach but does not provide empirical data or effect sizes; further research is needed to confirm its impact on clinical outcomes.

What is the main challenge with the availability of multiple oxybate formulations?▼

The main challenge is selecting and fine-tuning the appropriate therapy for each patient, which requires careful consideration of formulation differences and patient preferences.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Thorpy M. "Optimizing patient outcomes and empowering the patient-clinician partnership.." Sleep advances : a journal of the Sleep Research Society, 2026. PMID: 42488173 DOI: 10.1093/sleepadvances/zpag034
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.